Eikon Therapeutics, Inc. Common Stock (EIKN) — Strategic Asset Allocation Index
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Strategic Asset Allocation Index of 15.2% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $83.83 Million) total $83.83 Million, measured against net assets of $550.67 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see EIKN company net worth.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Eikon Therapeutics, Inc. Common Stock (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Eikon Therapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore EIKN shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|